Orchard Holdings, Inc

$80$125

Organovo Holdings, Inc., an early commercial stage company is engaged in designing and creation of functional and three-dimensional (3D) human tissues for the use in medical research and therapeutic field. The company develops 3D human tissue models through internal development and in collaboration with pharmaceutical, academic, and other partners. Its 3D human tissues could be employed in drug discovery and development, biological research, and as therapeutic implants for the treatment of damaged or degenerating tissues and organs.

Report ID:

UMHE21206

Published:

Jan-2022

Pages:

11

Industry:

HeadQuatered Country:

United States

Geography:

Clear
  Get a Free Sample
SKU: UMHE21205 Category:
Scope
Table of content
Companies Mentioned

Scope

“Overview of the company and its product offering
Detailed insight into its Strategy, Value, Product Portfolio, and Business Headquarter
Information on its recent developments including collaborations, and expansions among others”

You can also purchase parts of this report. Do you want to check out a section wise
price list?

“1.    Key Facts of the Company
2.    Growth Strategy
3.    Key Products & Services Offered
4.    SWOT Analysis
5.    Key Financials
6. Recent Developments
6.1 Product Launches”

Companies Mentioned

“CellSeed
EPISKIN
BIA Separations
Analytical Biological Services”